Isabel Tena

611 total citations
14 papers, 220 citations indexed

About

Isabel Tena is a scholar working on Oncology, Surgery and Genetics. According to data from OpenAlex, Isabel Tena has authored 14 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Surgery and 4 papers in Genetics. Recurrent topics in Isabel Tena's work include Adrenal and Paraganglionic Tumors (4 papers), BRCA gene mutations in cancer (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Isabel Tena is often cited by papers focused on Adrenal and Paraganglionic Tumors (4 papers), BRCA gene mutations in cancer (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Isabel Tena collaborates with scholars based in Spain, United States and Palestinian Territory. Isabel Tena's co-authors include Rami Alrezk, Karel Pacák, Miguel Arístegui, C. Ferrer Albiach, María Rosa Bella, Mercedes Robledo, Felicia A. Hanzu, Rocio García‐Carbonero, Mercedes Mitjavila and Abhishek Jha and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology and Frontiers in Endocrinology.

In The Last Decade

Isabel Tena

13 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabel Tena Spain	6	148	130	109	27	26	14	220
Samuel Backman Sweden	9	74 0.5×	95 0.7×	70 0.6×	20 0.7×	43 1.7×	11	177
María Currás-Freixes Spain	7	101 0.7×	132 1.0×	101 0.9×	12 0.4×	62 2.4×	8	209
Veronica Cheung Australia	4	117 0.8×	83 0.6×	79 0.7×	38 1.4×	18 0.7×	13	189
Karin van der Tuin Netherlands	6	86 0.6×	97 0.7×	48 0.4×	14 0.5×	31 1.2×	9	199
Maria Albuja‐Cruz United States	11	220 1.5×	194 1.5×	88 0.8×	6 0.2×	27 1.0×	17	301
Hilde Dannenberg Netherlands	11	269 1.8×	193 1.5×	264 2.4×	51 1.9×	58 2.2×	12	348
Tarek Abdel‐Aziz United Kingdom	9	133 0.9×	104 0.8×	33 0.3×	9 0.3×	26 1.0×	27	226
Angelica Malinoc Germany	6	122 0.8×	98 0.8×	114 1.0×	25 0.9×	63 2.4×	8	240
Anand K. Annamalai United Kingdom	8	123 0.8×	175 1.3×	42 0.4×	8 0.3×	20 0.8×	20	243
Sara G Creemers Netherlands	11	173 1.2×	145 1.1×	131 1.2×	17 0.6×	43 1.7×	16	291

Countries citing papers authored by Isabel Tena

Since Specialization

Citations

This map shows the geographic impact of Isabel Tena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Tena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Tena more than expected).

Fields of papers citing papers by Isabel Tena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Tena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Tena. The network helps show where Isabel Tena may publish in the future.

Co-authorship network of co-authors of Isabel Tena

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Tena. A scholar is included among the top collaborators of Isabel Tena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Tena. Isabel Tena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Granados, Ana Laura Ortega, Rosario García Campelo, Rafael López Castro, et al.. (2025). OA05.03 NIVIPI-Brain: Phase 2 Study of Nivolumab + Ipilimumab Combined With Chemotherapy in NSCLC With Synchronous Brain Metastases. Journal of Thoracic Oncology. 20(10). S19–S20.

Sánchez‐Conde, Matilde, Pilar Vizcarra, José Manuel Pérez-García, et al.. (2022). Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study. International Journal of Infectious Diseases. 123. 97–103. 6 indexed citations

García‐Carbonero, Rocio, Mercedes Mitjavila, Mercedes Robledo, et al.. (2021). Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clinical & Translational Oncology. 23(10). 1995–2019. 88 indexed citations

Tena, Isabel, et al.. (2021). Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families. Journal of Personalized Medicine. 11(6). 548–548. 5 indexed citations

Patel, Mayank, Isabel Tena, Abhishek Jha, David Taïeb, & Karel Pacák. (2021). Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World. Frontiers in Endocrinology. 12. 625312–625312. 23 indexed citations

García‐Casado, Zaida, Antonio Fernández‐Serra, Sarai Palanca, et al.. (2019). Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS). Hereditary Cancer in Clinical Practice. 17(1). 3–3. 11 indexed citations

Alrezk, Rami, et al.. (2018). Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging. Frontiers in Endocrinology. 9. 515–515. 67 indexed citations

Sáenz‐de‐Santa‐María, Inés, Nuria Valdés, Aurora Astudillo, et al.. (2018). Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas. Head & Neck. 41(1). 79–91. 5 indexed citations

Díez‐Obrero, Virginia, Eva Hernández‐Illán, M.I. Castillejo, et al.. (2017). Characterization of a novel POLD1 missense founder mutation in a Spanish population. The Journal of Gene Medicine. 19(4). 4 indexed citations

10.

Tena, Isabel, et al.. (2017). CP-127 Switching from intravenous to subcutaneous formulation of TRASTUZUMAB: costs and safety. A57.1–A57. 1 indexed citations

11.

Tena, Isabel, et al.. (2016). PS-069 Evaluation of post-chemotherapy toxicities in cancer patients who attended the emergency service. A244.1–A244. 1 indexed citations

12.

Tena, Isabel, et al.. (2016). CP-169 Effectiveness of biosimilar filgrastim vs original granulocyte-colony stimulating factor (G-CSF) in febrile neutropenia prevention in breast cancer patients receiving docetaxel/doxorubicin/cyclophosphamide (TAC). A75.1–A75. 2 indexed citations

13.

Juan-Fita, María José, Isabel Chirivella, Ana B. Sánchez, et al.. (2016). Locoregional relapse in BRCA1/2 breast cancer women treated with breast-conserving surgery.. Journal of Clinical Oncology. 34(15_suppl). 1527–1527. 1 indexed citations

14.

Guillém, Vicente, Antonio Llombart‐Cussac, Ángel Guerrero, et al.. (2006). Clinical response at 4 months to neoadjuvant letrozole predicts distant disease free survival in postmenopausal women with stage II-III ER/PgR-positive breast cancer. Journal of Clinical Oncology. 24(18_suppl). 10531–10531. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact